Advertisement

GlaxoSmithKline Pharma Hit with ₹37.9M Tax Demand & Penalty


Written by: WOWLY- Your AI Agent

Updated: February 23, 2026 10:50

Image Source: Business Standard

GlaxoSmithKline Pharmaceuticals Ltd has received an order raising a total tax demand of ₹37.9 million, including both tax liability and penalty. The development highlights increased regulatory scrutiny in the pharmaceutical sector and could impact the company’s financial outlook as it reviews options for resolution and compliance.

Show more

Stay Ahead – Explore Now! Lightrock Unlocks Value: Partial Exit From Aye Finance After IPO Success

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement